Efﬁcacy and Safety of IncobotulinumtoxinA (NT 201, Xeomin) in theTreatment of Blepharospasm—A Randomized Trial: Jankovic J et al.

Movement Disorders, Vol. 26, No. 8, 2011
DOI: 10.1002/mds.23658

Authors:

Joseph Jankovic, MD, 1*
Cynthia Comella, MD, 2

Angelika Hanschmann, 3

and Susanne Grafe, MD 3

Author Details:

1 Department of Neurology, Baylor College of Medicine, Houston, Texas, USA

2 Rush University, Chicago, Illinois, USA

3 Merz Pharmaceuticals GmbH, Frankfurt/Main, Germany.

Please click here!

Unsere Zertifizierer

Testimonials

Sorry, this entry is only available in Deutsch.

Erzählen Sie doch ein auch wenig von Ihren Erfahrungen mit IAB!

Get in touch with us!

Name (required)

E-Mail Address (required)

Your Message

If you send us requests via our contact form or email, your details from the contact form or email, including the contact data you have provided there, will be stored for the purpose of processing your request and in the event of follow-up questions. You are required to provide an email address to contact us. Your name is optional. Under no circumstances will we pass on this data without your consent. The legal basis for processing the data is our legitimate interest in responding to your request pursuant to Art. 6 para. 1 lit. f GDPR and, if applicable, Art. 6 para. 1 lit. b GDPR, provided that your request is aimed at concluding a contract. Your data will be deleted after final processing of your request, provided that there are no legal storage obligations to the contrary. You can object to the processing of your personal data at any time in the case of Art. 6 para. 1 lit. f GDPR.